EZH2 and neoplasm: Given that EZH2 inhibitors can modulate both anti-tumor and pro-tumor immune cell populations, a better understanding of the effect of EZH2 inhibitors on the MPM immune infiltrate will likely help physicians determine the most effective combination approaches.